Adalimumab-adbm injection, a biosimilar to Humira (adalimumab), has been made available by Boehringer Ingelheim.

Medicare parts B and D may cover Humira, including home injections and the drug itself in certain cases. Some programs may help with costs. Learn more here.

Medicare drug plans significantly boosted coverage of biosimilar versions of the Humira rheumatoid arthritis medicine this year, but nearly all of them failed to take steps that would encourage ...

GoodRx announced a new partnership with Boehringer Ingelheim to provide discounts for a biosimilar to rheumatoid arthritis drug Humira Thursday, adding to an increasingly competitive market.

Evernorth said more than 100,000 Accredo patients currently use Humira or a biosimilar. Plans for a $0 out-of-pocket Humira biosimilar offering was initially announced by Evernorth in March.

Abbott Laboratories Inc won a U.S. panel's support on Tuesday for wider use of its blockbuster rheumatoid arthritis drug, Humira, for treating a type of inflammatory bowel disease.